v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Summary of Financial Assets Measured at Fair Value on Recurring Basis

The following table summarizes the Company’s fair value hierarchy for its financial assets measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025, respectively (in thousands):

 

Fair Value Measurements as of

 

 

June 30, 2026

 

 

Fair Value

 

Level 1

 

Level 2

 

Level 3

 

Cash equivalents

 

 

 

 

 

 

 

 

Money market

$

1,051

 

$

1,051

 

$

 

$

 

Total cash equivalents

$

1,051

 

$

1,051

 

$

 

$

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

Treasury bills

$

3,738

 

$

3,738

 

$

 

$

 

Government bonds

 

2,483

 

 

2,483

 

 

 

 

 

Total Investments

$

6,221

 

$

6,221

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements as of

 

 

December 31, 2025

 

 

Fair Value

 

Level 1

 

Level 2

 

Level 3

 

Cash equivalents

 

 

 

 

 

 

 

 

Money market

$

1,513

 

$

1,513

 

$

 

$

 

Treasury bills

 

6,983

 

 

6,983

 

 

 

 

 

Total cash equivalents

$

8,496

 

$

8,496

 

$

 

$

 

 

 

 

 

 

 

 

 

 

Investments

 

 

 

 

 

 

 

 

Treasury bills

$

2,853

 

$

2,853

 

$

 

$

 

Government agency bonds

 

1,503

 

 

1,503

 

 

 

 

 

Total Investments

$

4,356

 

$

4,356

 

$

 

$

 

 

Schedule of Change in Fair Value of Liability

The following table provides a roll forward of the fair value of liability classified common stock warrants during the six months ended June 30, 2025 (in thousands):

 

 

February 2025 Warrants

 

 

March 2025 Series A Warrants

 

 

March 2025 Series B Warrants

 

 

Total

 

Beginning balance as of January 1, 2025

 

$

 

 

$

 

 

$

 

 

$

 

Issuance

 

 

2,762

 

 

 

2,005

 

 

 

11,243

 

 

 

16,010

 

Change in fair value

 

 

(2,231

)

 

 

335

 

 

 

5,043

 

 

 

3,147

 

Settlement

 

 

(531

)

 

 

 

 

 

(858

)

 

 

(1,389

)

Modification and extinguishment

 

 

 

 

 

(2,340

)

 

 

(4,461

)

 

 

(6,801

)

Reclassified to equity

 

 

 

 

 

 

 

 

(10,967

)

 

 

(10,967

)

Ending balance as of June 30, 2025

 

$

 

 

$

 

 

$

 

 

$

 

Convertible Notes [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value

As detailed in Note 12 Stockholders' Equity, the Company elected to account for convertible notes (consisting of funding notes and exchange notes) issued on February 13, 2025 at fair value as of the issuance date and immediately before their settlement date of March 4, 2025. The convertible notes were valued using the binomial lattice model with the following key level 3 inputs:

 

 

At issuance

 

 

At settlement

 

Interest rate

 

4.18% - 4.28%

 

 

 

3.99

%

Remaining term (years)

 

 

1.0

 

 

 

0.94

 

Volatility

 

 

77.5

%

 

 

119.2

%

Fair value of common stock

 

$

1.20

 

 

$

0.30

 

Schedule of Change in Fair Value of Liability

The following table provides a roll forward of the fair value of the convertible notes during the six months ended June 30, 2025 (in thousands):

 

 

Funding Notes

 

 

Exchange Notes

 

Beginning balance as of January 1, 2025

 

$

 

 

$

 

Issuance

 

 

3,968

 

 

 

3,763

 

Change in fair value

 

 

(265

)

 

 

(251

)

Settlement

 

 

(3,703

)

 

 

(3,512

)

Ending balance as of June 30, 2025

 

$

 

 

$

 

March 2025 Series A and B Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value the Company issued March 2025 Series A and March 2025 Series B common stock warrants in connection with the March 2025 Private Placement. The March 2025 Series A and March 2025 Series B common stock warrants were accounted for as liabilities at fair value at their issuance date, and immediately prior to their extinguishment and modification, respectively, on June 17, 2025. The March 2025 Series A and March 2025 Series B common stock warrants were valued using the Monte Carlo simulation, with the following key level 3 inputs:

 

 

At issuance

 

 

At modification and extinguishment

 

Interest rate

 

 

3.98

%

 

 

3.91

%

Remaining term (years)

 

 

6.1

 

 

 

4.9

 

Volatility

 

 

123.7

%

 

 

135.6

%

Series B Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value

The March 2025 Series B Warrants were valued immediately prior to exercise, using the Monte Carlo simulation with the following inputs for the exercises that occurred before the modification on June 17, 2025:

 

 

At exercise

Interest rate

 

3.85% - 4.06%

Remaining term (years)

 

4.9 - 5.0

Volatility

 

133.9% - 135.8%

February 2025 Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Summary of Key Level 3 Inputs Used in Valuation of Warrants Liability at Fair Value

In addition, the February 2025 Warrants issued in connection with the Funding Notes were required to be classified as liabilities and recorded at fair value. The Company estimated the fair value of the February 2025 Warrants using the Black Scholes model at issuance as of February 13, 2025 and as of their redemption date of March 4, 2025, using the following level 3 inputs:

 

 

At issuance

 

 

At settlement

 

Interest rate

 

 

4.30

%

 

 

4.30

%

Remaining term (years)

 

 

5.0

 

 

 

4.95

 

Volatility

 

 

98.5

%

 

 

102.1

%

Fair value of common stock

 

$

1.20

 

 

$

0.30